Dr. Galderisi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1341 Sw Custer Dr
Portland, OR 97219Phone+1 503-459-4974
Summary
- Chad Galderisi, DO, is a pathology specialist located in Portland, OR, with subspecialties in Molecular Genetics, Anatomic Pathology, and Clinical Pathology. He completed his education at the Philadelphia College of Osteopathic Medicine in 2001 and his residency in Pathology-Anatomic and Clinical at Penn State Milton S Hershey Medical Center from 2001 to 2005. Since 2019, he has been serving as the VP and Global Medical Director at ICON Specialty Labs. He has contributed to several publications, including studies on breast cancer and test development for acute lymphoblastic leukemia, with some articles being widely cited.
Education & Training
- Penn State Milton S Hershey Medical CenterResidency, Pathology-Anatomic and Clinical, 2001 - 2005
- Philadelphia College of Osteopathic MedicineClass of 2001
Certifications & Licensure
- NY State License 2024 - 2026
- CA State License 2023 - 2025
- MA State License 2012 - 2025
- OR State License 2004 - 2025
- WA State License 2010 - 2025
- PA State License 2001 - 2005
- American Board of Pathology Anatomic Pathology
- American Board of Pathology Pathology - Molecular Genetic
Publications & Presentations
PubMed
- A Novel Next-Generation Sequencing Assay for the Identification of BCR::ABL1 Transcript Type and Accurate and Sensitive Detection of TKI-Resistant Mutations.Zhenyu Yan, Lin Shi, Wei Li, Weihua Liu, Chad Galderisi
The Journal of Applied Laboratory Medicine. 2024-11-04 - 19 citationsSystematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study.Balazs Acs, Samuel C Y Leung, Kelley M Kidwell, Indu Arun, Renaldas Augulis
Modern Pathology. 2022-10-01 - 67 citationsAn international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancerDavid L. Rimm, Samuel C Y Leung, Lisa M. McShane, Yalai Bai, Anita Bane
Modern Pathology. 2019-01-01
Journal Articles
- An International Multicenter Study to Evaluate Reproducibility of Automated Scoring for Assessment of Ki67 in Breast CancerRichard Levenson, David L Rimm, Daniel F Hayes, Chad Galderisi, Liron Pantanowitz, Nature
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: